M. Gibbs

Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

Zheng-Yi Zhou, Wenxi Tang, H. Loong, 2022, JTO clinical and research reports.

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020, Cost Effectiveness and Resource Allocation.

Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020 .